37 Followers on Owler

HPN Investments

HPN has invested in 13 companies and its latest investment was Celsius Therapeutics on Mar 23, 2022

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

Celsius Therapeutics is a Massachusetts-based biotechnology company that develops and commercializes single-cell RNA therapies to treat cancer and autoimmunity diseases.
$83M
Mar 23, 2022
-
InterVenn is a California-based AI glycoproteomics platform that offers solutions such as biomarker research and liquid biopsy assay development for the healthcare industry.
$201M
Aug 01, 2021
-
Digital Diagnostics is an Iowa-based AI diagnostic platform that offers solutions such as image analysis and EMR integration for the healthcare industry.
$15M
May 28, 2020
-
RubiconMD is a New York-based E-consult platform that allows primary care providers to connect with specialists for medical guidance and opinions.
$18M
Feb 06, 2020
-
$5M
Jan 06, 2020
-

Frequently Asked Questions about HPN

  1. What is HPN investing in?

    HPN has invested in 13 companies including Celsius Therapeutics, InterVenn and Digital Diagnostics
  2. What company did HPN invest in?

    HPN invested in a total 13 companies including Celsius Therapeutics, InterVenn and Digital Diagnostics
  1. What are the top 5 investments by HPN?

    The top companies in which HPN invested are Celsius Therapeutics, InterVenn, Digital Diagnostics, RubiconMD and Aitia